Davis's Drug Guide
afamitresgene autoleucel
General
Genetic Implications:
Pronunciation:
a-fam-i-tres-jeen aw-toe-loo-sel
Trade Name(s)
- Tecelra
Ther. Class.
Pharm. Class.
temporary class
autologous gene therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Afamitresgene Autoleucel." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580149/all/afamitresgene_autoleucel.
Vallerand AHA, Sanoski CAC. Afamitresgene autoleucel. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580149/all/afamitresgene_autoleucel. Accessed August 5, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Afamitresgene autoleucel. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580149/all/afamitresgene_autoleucel
Vallerand AHA, Sanoski CAC. Afamitresgene Autoleucel [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 05]. Available from: https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580149/all/afamitresgene_autoleucel.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - afamitresgene autoleucel
ID - 3580149
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580149/all/afamitresgene_autoleucel
PB - F.A. Davis Company
ET - 20
DB - Harriet Lane
DP - Unbound Medicine
ER -
